172 related articles for article (PubMed ID: 18644960)
61. Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.
Rouan MC; Lounis N; Gevers T; Dillen L; Gilissen R; Raoof A; Andries K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1444-51. PubMed ID: 22155815
[TBL] [Abstract][Full Text] [Related]
62. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA
Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743
[TBL] [Abstract][Full Text] [Related]
63. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Paramasivan CN; Herbert D; Prabhakar R
Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
[TBL] [Abstract][Full Text] [Related]
64. Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.
Rose DN
Ann Intern Med; 1998 Nov; 129(10):779-86. PubMed ID: 9841583
[TBL] [Abstract][Full Text] [Related]
65. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Dorman SE; Johnson JL; Goldberg S; Muzanye G; Padayatchi N; Bozeman L; Heilig CM; Bernardo J; Choudhri S; Grosset JH; Guy E; Guyadeen P; Leus MC; Maltas G; Menzies D; Nuermberger EL; Villarino M; Vernon A; Chaisson RE;
Am J Respir Crit Care Med; 2009 Aug; 180(3):273-80. PubMed ID: 19406981
[TBL] [Abstract][Full Text] [Related]
66. Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
Liu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Harrison T; Davies G; Coates A; Hu Y
J Antimicrob Chemother; 2018 Mar; 73(3):724-731. PubMed ID: 29244108
[TBL] [Abstract][Full Text] [Related]
67. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
68. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
69. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Su WJ; Perng RP
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
[TBL] [Abstract][Full Text] [Related]
70. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Vilchèze C; Kim J; Jacobs WR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757
[TBL] [Abstract][Full Text] [Related]
71. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
Martínez E; Collazos J; Mayo J
Clin Infect Dis; 1998 Nov; 27(5):1329-30. PubMed ID: 9827298
[No Abstract] [Full Text] [Related]
72. Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.
Shang S; Shanley CA; Caraway ML; Orme EA; Henao-Tamayo M; Hascall-Dove L; Ackart D; Lenaerts AJ; Basaraba RJ; Orme IM; Ordway DJ
Antimicrob Agents Chemother; 2011 Jan; 55(1):124-31. PubMed ID: 20937788
[TBL] [Abstract][Full Text] [Related]
73. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
Kawakami K
Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
[TBL] [Abstract][Full Text] [Related]
74. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
[TBL] [Abstract][Full Text] [Related]
75. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.
Deol P; Khuller GK; Joshi K
Antimicrob Agents Chemother; 1997 Jun; 41(6):1211-4. PubMed ID: 9174172
[TBL] [Abstract][Full Text] [Related]
76. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
77. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
Wada M
Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090
[TBL] [Abstract][Full Text] [Related]
78. Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
Dutta NK; Pinn ML; Karakousis PC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5567-9. PubMed ID: 24936590
[TBL] [Abstract][Full Text] [Related]
79. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
[TBL] [Abstract][Full Text] [Related]
80. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
